Quick Answer
IMPACT BIOMEDICAL INC. reported Shares Outstanding of 104.62 million shares for fiscal year 2025.
IMPACT BIOMEDICAL INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 104.62M | +809.4% |
| 2024 | 11.50M | +15.0% |
| 2023 | 10.00M | -92.0% |
| 2023 | 125.07M | +77.4% |
| 2022 | 70.50M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 12.19M | +5.9% | +0.0% |
| June 30, 2025 | 12.19M | +21.9% | +0.8% |
| March 31, 2025 | 12.09M | +20.9% | +5.1% |
| December 31, 2024 | 11.50M | +15.0% | +0.0% |
| September 30, 2024 | 11.50M | -83.7% | +15.1% |
| June 30, 2024 | 10.00M | -99.7% | -0.0% |
| March 31, 2024 | 10.00M | — | +0.0% |
| December 31, 2023 | 10.00M | -85.8% | -85.8% |
- IMPACT BIOMEDICAL INC. showed an increase of +809.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, IMPACT BIOMEDICAL INC.’s shares outstanding has grown by 48.4% (from 70.50 million shares to 104.62 million shares).
- The most recent figure is from IMPACT BIOMEDICAL INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: